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Abstract 
To assess whether joint pain or radiographic osteoarthritis (ROA) of the knee and 
hand is associated with all-cause and disease specific mortality in middle-aged 
women.  
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Methods: 
Four subgroups from the prospective community-based Chingford Cohort Study 
were identified based on presence/absence of pain and ROA at baseline: (Pain-
/ROA-; Pain+/ROA-; Pain-/ROA+; Pain+/ROA+). Pain was defined as side-specific 
pain in the preceding month, while side-specific ROA was defined as K-L Grade >2. 
All-cause, cardiovascular (CVD) and cancer related mortality over the 23-year 
follow-up was based on information collected by the Office for National Statistics. 
Associations between subgroups and all-cause/cause-specific mortality were 
assessed using Cox regression, adjusting for age, BMI, typical cardiovascular risk 
factors, occupation, past physical activity, existing CVD disease, glucose levels and 
medication use. 
 
Results:  
821 and 808 women were included for knee and hand analyses respectively. 
Compared to the knee Pain-/ROA- group, the Pain+/ROA- group had an increased 
risk of CVD-specific mortality (hazard ratio 2.93 (95%CI, 1.47-5.85)), while the 
knee Pain+/ROA+ group had an increased HR of 1.97 (95%CI, 1.23-3.17) for all-
cause and 3.57 (95%CI, 1.53-8.34) for CVD-specific mortality. We found no 
association between hand OA and mortality. 
 
Conclusions:  
We found a significantly increased risk of all-cause and CVD-specific mortality in 
women experiencing knee pain with or without ROA but not ROA alone. No 
relationship was found between hand OA and mortality risk.  This suggests that 
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knee pain, more than structural changes of OA is the main driver of excess mortality in 
patients with OA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Osteoarthritis (OA) is the most common form of arthritis and a 
significant contributor of musculoskeletal disability burden in the 
developed world. (1)  In the population above 55 years old, one in four 
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reports frequent knee pain and have evidence of radiographic knee 
osteoarthritis (KOA). (2) The lifetime risk of receiving a total knee 
replacement at age 50 is of 8.1% for men and 10.8% for women. (3) 
The prevalence of symptomatic hand OA is 8.2% and 15.9% in men 
and women respectively. (4)    
There is growing evidence that low-grade systemic inflammation, 
linked with adipose tissue, is associated with joint pain (5-7), incidence 
of radiographic changes (8, 9), development of cardiovascular disease 
(CVD), (10-12) and also have a role in the cancer pathogenesis. (13) 
Compared to individuals with no OA, participants with total joint 
replacements have a 26% increased risk of CVD. (14) Furthermore, a 
younger middle-aged population with OA have a 5-fold increased 
prevalence of metabolic syndrome. (15, 16) 
The strongest evidence of a relationship between OA and mortality 
comes from an observational study where patients with symptomatic 
radiographic KOA and/or hip OA were selected and found to be at 
increased mortality risk compared with general population. (17)  A 
more recent study demonstrates a borderline significant association 
between excess mortality and symptomatic (but not radiographic) 
KOA alone.(18)  Hand OA was associated with a risk of premature CVD 
death in the Finnish population aged 30 years and over. (19, 20) In 
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contrast, a more recent publication demonstrates no association with 
an excess mortality and hand OA, despite increased risk of coronary 
heart disease events in a population with symptomatic hand OA. (21)  
It is currently unclear whether symptomatic or radiographic only OA is 
associated with excess mortality. The aim of our study was to examine 
the relationship between knee and hand OA and the risk of mortality in 
a longitudinal community-based cohort with 23 years of follow-up.   
Participants were divided into four subgroups based on presence or 
absence of pain and radiographic OA (ROA).  
 
METHODS 
Study Population 
Characteristics of the Chingford study have been described in detail 
previously. (22) Briefly, in Chingford, North London, UK, all women 
aged 45-64 years from the register of a large general practice were 
contacted in 1988-1989 and asked to participate in a population-based 
study to evaluate risk factors for osteoporosis and OA. Among 1353 
women contacted, 1003 (78% response rate) attended the baseline 
visit and have since been examined annually. This cohort has been 
shown to be representative of women in England. (22) 
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Inclusion criteria 
We included 821 women for knee and 808 for hand analyses with 
available data on both pain and radiographic KOA or hand OA. Women 
with the following diseases (n=43) at baseline or any point of follow-
up were excluded from analysis: Rheumatoid arthritis, psoriatic 
arthritis, gout, Paget’s disease, polio, cerebral palsy and chronic 
inflammatory demyelinating neuropathy. Two participants were 
excluded due to lack of time-to-death data. Further 137 women for 
knee and 150 for hand analyses were excluded due to lack of pain 
and/or radiographic data at baseline (Figure 1). Characteristics of the 
participants without baseline radiographic or pain data were similar 
with those included for analyses. 
Assessment of Mortality 
The outcomes of interest were all-cause and cause-specific mortality 
from cardiovascular (CVD) and cancer, based on available data up to 
August 2014. The Health and Social Care Information Centre provided 
detailed mortality information on the Chingford cohort based on the 
information collected by the Office for National Statistics from civil 
registration records.  The cause of death was based on the information 
from death certificates. For the cause specific mortality, we reviewed 
all CVD and cancer related deaths data from death certificates. In seven 
cases of cardiovascular mortality the cause of death was changed to 
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cancer related mortality, if the direct cause of death was a complication 
of cancer or its treatment. The cumulative number of deaths over the 
23 years (median 21.7 years (IQR: 21.2-22.3)) of follow-up was 223 
women (22.2%) out of the total sample of 1,003 women. CVD mortality 
accounted for 29% (n=64), cancer for 45% (n=100) and other diseases 
for 26% (n=59) of all-cause mortality. Time to event was assessed 
from year 3 until death, or the end of the follow-up (August 15, 2014). 
 
Assessment of joint-specific OA and pain 
A physical examination at baseline (year 1) was performed to assess 
anteroposterior (AP) radiographs of the hands and weight-bearing AP 
radiographs of the knees. The protocols for radiographic grading and 
reproducibility for both knee and hand OA and for this study have been 
previously reported. (23-26) 
Women were classified as having radiographic KOA if they had a 
Kellgren-Lawrence (K/L) OA grade of 2 or more in at least one knee at 
baseline. Hand radiographs were also graded for OA. Summary scores 
of distal interphalangeal (DIP), proximal interphalangeal (PIP) and 
first carpometacarpal (CMC) joints were defined as the number of 
joints with K/L grade≥2, while radiographic hand OA in any hand joint 
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was defined as positive if the K/L score in at least one joint was 2 or 
greater. 
 
Knee and hand pain was assessed at year 3 as part of a self-
administered questionnaire. (27) Women were asked if they had 
experienced any knee/hand pain in the past month and the number of 
days this had occurred. Knee/hand pain was classified as positive for 
either knee/hand if “yes” and “more than 0 days” were reported. 
Joint-specific OA and pain was classified into four subgroups based on 
presence and absence of pain and ROA:  
1) Neither ROA nor pain (Pain-/ROA-: reference category).  
2) ROA (Pain-/ROA+).  
3) Pain only (Pain+/ROA-).  
4) Painful ROA (Pain+/ROA+: joint(s) with ROA and pain in the same 
side).   
Women with ROA only in one side and pain only in the contralateral 
side were classified as having ROA+/Pain- only. 
 
Potential confounders 
We assessed information on potential confounders at year 3. Socio-
demographic covariates included age and occupation (“Manual” versus 
 10 
 
“Non-manual”). Health-related behaviours were physical activity at age 
30 and smoking. Physical activity (PA) at age 30 was assessed by the 
following question: “Were you a physically active person at age 30?”. 
Smokers were classifies as never smoked/ex-smoker or currently 
smoking. Current and past CVD disease was ascertained by asking the 
women if they had any CVD disease. We included all risk factors for 
heart disease that are part of the Framingham Heart Study Risk 
Assessment. (28) The biological factors included were body mass index 
(BMI), systolic blood pressure (BP), total and high-density lipoprotein 
(HDL) cholesterol and glucose. Body mass index (BMI) was calculated 
at baseline and divided into two groups: “non-obese” (BMI<30 kg/m2) 
and “obese” (BMI ≥30 kg/m2). Total and HDL cholesterol and glucose 
were measured by fasting serum samples taken (29). For the analysis, 
systolic BP, total and HDL cholesterol and glucose were treated as 
continuous variables. BP medication, anti-inflammatory drugs 
(NSAIDs) and hormone replacement therapy (HRT) use were coded as 
dichotomous variables with a value of 1 if the women reported taking 
the medication and 0 otherwise.  
 
 11 
 
Statistical Analysis 
All analyses were conducted using Stata version 13 statistical software 
(StataCorp, College Station, Texas) and took place separately for knee 
and hand. Multiple imputation using chained equations was used to 
investigate the impact of missing potential confounders, while 100 
imputed datasets were generated using all potential confounders 
(including all-cause mortality and log transformed survival time) and 
estimated parameters were combined using Rubin’s rules. Kaplan-
Meier survival curves for all-cause mortality in joint-specific OA and 
pain subgroups were estimated. 
The association between joint-specific OA and pain subgroups (knee 
and hand) and all-cause and cause-specific mortality was assessed 
using Cox proportional hazards regression models to estimate hazard 
ratios (HRs) and 95% confidence intervals (95%CI). Three models 
were used to assess this association:  
Model 1) was age-adjusted.  
Model 2) added risk factors from Framingham Risk Score (smoking, 
total cholesterol, HDL-cholesterol, systolic BP and BP medication).  
Model 3) added the remaining potential confounders (occupation, HRT 
use, past physical activity, BMI, current/previous CVD disease, Non-
ASA NSAIDs and glucose levels).  
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In the analyses of specific cause of death, deaths attributed to other 
causes were treated as censored at the time of death. Proportional 
hazards assumption was examined by Schoenfeld residuals. There was 
no evidence showing that the hazards were not proportional over the 
follow-up period studied. 
Four sensitivity analyses were conducted. First, we excluded women 
who underwent joint-specific surgery at any point during follow-up. 
Second, all deaths occurring during the first 12 months of follow-up 
were excluded. Third, with a radiographic hand OA defined as positive 
if the K/L score in at least two joints was 2 or greater. Forth, with 
available crude measures of PA. This was assessed by the following 
question ‘'How many times per week do you engage in activity that 
makes you sweat?”. 
 
RESULTS 
From 1993 to 2014 (median follow-up of 21.7 years (range: 21.2-
22.3)), 166 and 163 deaths (~20%) were confirmed by death 
certificate among the knee and hand OA and pain study sample, 
respectively. Potential confounders according to knee and hand OA and 
pain categories are presented in Table 1 and 2, respectively. Compared 
with women without OA (Pain-/ROA-), women with ROA (Pain+ and 
Pain-) were older and had higher systolic BP levels (Tables 1 and 2). 
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Women with painful knee (ROA+ or ROA-) were more likely to use 
Non-ASA NSAIDs. (Table 1) Women with knee or hand pain 
(Pain+/ROA-) were also more likely to be using HRT medication, 
compared with the other subgroups.  
Kaplan-Meier survival curves for all-cause mortality according to KOA 
and pain (fig. 2a) and hand OA and pain categories (fig. 2b) are 
presented in figure 2. Women with painful knee/hand ROA had a 
greater risk of all-cause mortality compared with women with neither 
knee/hand pain nor ROA (log-rank test p-value ≤ 0.001). 
Results from Cox proportional hazard models estimating the mortality 
risk according to knee and hand OA and pain categories are shown in 
tables 3 and 4. In the age-adjusted model, women with knee pain and 
no ROA had a 49% increased risk of dying from all-cause mortality, 
compared with those with neither knee pain nor ROA [HR 1.49 95%CI 
1.04-2.14; p-value=0.029]. The mortality risk was stronger among 
women with painful knee ROA, reaching a 97% increase in mortality 
risk in an age-adjusted model [HR 1.97 95%CI, 1.23-3.17; p-
value=0.005] (Model 1; Table 4). 
After adjustment for the factors from Framingham Risk Score 
Factors(Table 4; Model 2), the HRs increased slightly for painful knee 
subgroups (ROA+, ROA-) (1.55 [95%CI, 1.07-2.22] and 2.06 [95%CI, 
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1.27-3.33], respectively) (Model 2; Table 4). The relationship remained 
unchanged even after further adjusting for all other covariates (Model 
3; Table 4). In contrast, knee ROA alone was not associated with 
mortality in any of the three models.  
The magnitude of association between knee pain subgroups 
(Pain+/ROA- and Pain+/ROA+) and mortality was the strongest for 
CVD-specific mortality in all models. Compared with women with 
neither knee pain nor ROA, the HR associated with knee pain only 
(Pain+/ROA-) was 3.25 [95%CI, 1.64-6.43] and with painful knee ROA 
(Pain+/ROA+) was 4.19 [95%CI, 1.87-9.40], after adjustment for 
Framingham Risk Score factors (Model 2; Table 4). Further inclusion of 
all other covariates produced an almost negligible reduction in the HR 
for CVD-specific mortality (Model 3; Table 4). No statistically 
significant associations were found for cancer-specific mortality.  
Additionally, there were no associations between hand pain, with or 
without ROA, and all-cause or cause-specific mortality after adjustment 
for other covariates (Table 4). 
No substantial differences in the results were observed when women 
who died during the first 12 months of follow-up (n=2), or when 
women who underwent knee replacement (for knee analysis) during 
the follow-up (n=29) were excluded (data not shown). 
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DISCUSSION 
In this prospective community-based study of middle-aged women, we 
found a significant association between knee pain, with or without 
radiographic OA, and an increased risk of all-cause and CVD-specific 
mortality. We found no association between knee ROA only (Pain-
/ROA+) and decreased survival, although subjects with symptomatic 
ROA (Pain+/ROA+) had the highest risk of both all-cause and CVD-
specific mortality. No relationship was found between hand OA and 
mortality risk.  
 
There are conflicting results between observational studies on the 
impact of knee and hand OA on early mortality.  Cerhan et al, found 
that radiographic OA of hands, knees and the cervical spine was 
associated with decreased survival of middle-aged women who 
worked in the radium dial-painting industry, when compared to 
participants without ROA. (30) A systematic review on this subject 
found moderate evidence of increased mortality among participants 
with OA compared with the general population. (31) Two studies 
based on the Finish national health survey reported modest 
association between advanced radiographic hand OA and risk of early 
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mortality. (19, 20) However, Haugen et al have not confirmed those 
findings in the Framingham Study. (21)  
 
Nüesch and colleagues utilised a large selected population-based 
sample of men and women with symptomatic radiographic knee 
and/or hip OA and compared age and sex standardised mortality ratios 
after a median of 14 years’ follow-up. (17, 32) They reported a 
significant excess in all-cause, CVD- and dementia-related mortality. 
Liu et al found that participants from two different cohorts of patients 
consulting health professionals for their OA were not at higher risk of 
death than the general population (mean follow-up time below 7 
years). (33) Hawker and colleagues showed that increased walking 
disability, use of walking aids and poor baseline function are 
associated with excess all-cause mortality in individuals with hip and 
KOA symptoms. (32) . The main limitations of the previous studies 
include:  
• Relatively short follow-up,  
• Selection towards participants with symptomatic radiographic 
OA (34),  
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• Comparison with controls from population mortality registers or 
participants with no ROA, with no study using a comparison 
group without pain and ROA. 
 
This paper confirms strong independent associations between painful 
knee (but not hand) OA and excess mortality. (17, 21) This relationship 
is independent from the majority of known CVD risk factors and not 
attenuated by non-ASA NSAIDs use, which corresponds with previous 
findings (35). 
We have found that any self-reported knee pain in the past month, 
with or without radiographic KOA changes, but not symptomatic hand 
OA or radiographic KOA alone, is a significant predictor of early CVD 
mortality. There are number of plausible explanations for our findings, 
which are not mutually exclusive.  The most  biologically plausible 
mechanism for the causal association is that the knee pain results in 
sedentary behaviour, poor cardiovascular fitness and early mortality. 
This is supported by some observational studies(32, 36, 37) and by the 
fact that only 7.7% women with KOA meet recommended PA 
guidelines.(38) However, an alternative pathway might be presented 
where painful KOA is an early sign of metabolic dysregulation, leading 
to CVD problems and premature death. Adipose tissue associated 
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inflammation is considered to be a common mechanism precipitating 
development of CVD and painful OA. (8, 11, 39, 40) Women with KOA 
have higher levels of markers of atherosclerosis.(41) Physical activity 
is also an important mediator of this inflammatory response (42) and 
inactivity linked with painful KOA might accelerated metabolic 
dysregulation.(43, 44) The pain in KOA fluctuates (27) and people 
commonly limit the activities associated with their symptoms and 
perceive physical activity (PA) to lead to the disease progression.(45, 
46) Despite, clear evidence suggesting that PA improves pain, quality 
of life and minimises disability in individuals with KOA (47), we lack 
evidence supporting that any interventions in KOA patients improve 
PA levels or cardiovascular fitness in the longer term.(48, 49)   
 
To our knowledge, this is the first longitudinal prospective community-
based cohort with over two decades follow-up looking at the effect of 
knee and hand pain with and without radiographic OA on all-cause and 
disease specific mortality in middle-aged women. Participants' 
selection to enter this study was not based on symptomatology or 
radiographic features. The comparison group is part of the same 
population and has no radiographic disease at baseline nor side-
specific pain. With comprehensive baseline data, we adjusted our 
 19 
 
analysis for potentially important multiple confounders, including all 
risk factors from the Framingham Heart Study. We performed a 
sensitivity analysis with a radiographic hand OA was defined as 
positive if the K/L score in at least two joints was 2 or greater, that 
when adjusted for, did not attenuate the findings. 
 
 
Some potential limitations are worth mentioning. Findings of this 
study are limited to middle-aged and predominantly Caucasian 
women. In multivariable analysis of groups, we used baseline values of 
covariates, but those values may change over time and have time-
dependent effects on OA and mortality outcomes that we would not be 
able to comment on in this analysis. This analysis is likely to 
underestimate the absolute risk of the exposure groups due to the fact 
that participants from the control group (ROA-/Pain-) remain in the 
original group even if they develop pain and/or ROA over time. .In this 
study all exposure categories have this immortal time period. (50) The 
other important limitation of this study is the fact that radiographs of 
the hands and knees were taken three years before knee and hand pain 
assessment. To mitigate against this, outcomes were measure from 
year 3 onwards. The physical activity and function is another potential 
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residual confounding. We performed a sensitivity analysis using an 
available crude measures of PA, that when adjusted for, did not 
attenuate the findings.   
 
In conclusion, knee pain with or without radiographic OA in middle-
aged women is associated with an increased all-cause and CVD 
mortality only. The highest risk was found in subjects with both pain 
and ROA, with no association found with ROA alone. In addition, there 
were no associations between hand pain, with or without ROA, and all-
cause and specific-cause mortality. The link behind this relationship is 
not completely understood. Further research analysing the 
longitudinal differences in the groups’ characteristics associated with 
CVD mortality is required to identify potential underlying mechanisms. 
Additional studies of men-only or mixed gender cohorts are needed to 
confirm generalizability of these findings.   
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Figure 1. A flow diagram of participants included and excluded for each analysis.  
 
 
 
* Rheumatoid arthritis, psoriatic arthritis, gout, Paget’s disease, polio, cerebral palsy and chronic 
inflammatory demyelinating neuropathy 
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Table 1. Descriptive characteristics across knee status categories 
Characteristic 
Neither 
ROA nor 
pain 
(n=524) 
ROA  
only (n=64) 
Pain only 
(n=176) 
Symptomatic 
OA (n=57) 
p-
value 
Age, years, mean (SD) 55.2 (5.8) 58.7 (6.3) 56.4 (5.8) 59.6 (4.9) 0.000 
Occupation, n (%)     0.042 
Manual 79 (15.1) 11 (17.2) 40 (22.7) 8 (8.8)  
Non-Manual 440 (84.0) 52 (81.3) 135 (76.7) 52 (91.2)  
HRT, n (%)     0.045 
No 343 (65.5) 44 (68.8) 100 (56.8) 39 (68.4)  
Yes 164 (31.3) 16 (25.0) 74 (42.1) 17 (29.8)  
Smoking, n (%)*     0.706 
Never/ex-smoker 401 (76.5) 53 (82.8) 137 (77.8) 45 (79.0)  
Smoker 123 (23.5) 11 (17.2) 39 (22.2) 12 (21.1)  
Physical activity at age 30, n (%)     0.328 
No 101 (19.3) 13 (20.3) 25 (14.2) 8 (14.0)  
Yes 413 (78.8) 50 (78.1) 150 (85.2) 49 (86.0)  
Body Mass Index, n (%)     0.002 
Non-obese (<30 kg/m2) 316 (60.3) 39 (60.9) 118 (67.1) 34 (59.7)  
Obese (≥30 kg/m2) 41 (7.8) 14 (21.9) 25 (14.2) 13 (22.8)  
Previous CVD disease, n (%)     0.436 
No 489 (93.3) 58 (90.6) 163 (92.6) 53 (93.0)  
Yes 18 (3.4) 2 (3.1) 11 (6.3) 3 (5.3)  
BP medication, n (%)*     0.008 
No 454 (86.6) 51 (79.7) 149 (84.7) 40 (70.2)  
Yes 70 (13.4) 13 (20.3) 27 (15.3) 17 (29.8)  
Non-ASA NSAIDs medication, n 
(%) 
    0.010 
No 507 (96.8) 63 (98.4) 163 (92.6) 51 (89.5)  
Yes 17 (3.2) 1 (1.6) 13 (7.4) 6 (10.5)  
Systolic BP, mmHg, mean (SD)* 124.8 (20.5) 129.7 (17.6) 127.1 (17.7) 132.8 (19.7) 0.029 
Total cholesterol, mg/dL, mean 
(SD)* 
6.6 (1.4) 6.7 (1.3) 6.8 (1.4) 7.1 (1.2) 0.072 
HDL-cholesterol, mg/dL, mean 
(SD)* 
1.7 (0.4) 1.6 (0.4) 1.7 (0.4) 1.7 (0.5) 0.263 
Glucose, mmol/L, mean (SD) 4.9 (0.6) 5.0 (0.8) 4.9 (0.7) 5.1 (0.6) 0.130 
OA=Osteoarthritis; IQR=Interquartile range; SD= Standard deviation; BP= blood pressure; HDL= High-density 
lipoprotein; NSAIDs=nonsteroidal anti-inflammatory drugs.*Framingham Risk Score Factors 
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Table 2. Descriptive characteristics across hand status categories 
Characteristic 
Neither ROA 
nor pain 
(n=416) 
ROA only 
(n=166) 
Pain only 
(n=127) 
Symptomatic OA 
(n=99) 
p-value 
Age, years, mean (SD) 54.0 (5.5) 59.3 (5.5) 55.4 (5.3) 60.0 (5.1) 0.000 
Occupation, n (%)     0.688 
Manual 70 (16.8) 24 (14.5) 24 (18.9) 14 (14.1)  
Non-Manual 341 (82.0) 141 (84.9) 103 (81.1) 85 (85.9)  
HRT, n (%)     0.012 
No 271 (65.1) 114 (68.7) 67 (52.8) 64 (64.7)  
Yes 130 (31.3) 46 (27.7) 58 (45.7) 34 (34.3)  
Smoking, n (%)*     0.996 
Never/ex-smoker 323 (77.6) 130 (78.3) 98 (77.2) 77 (77.8)  
Smoker 93 (22.4) 36 (21.7) 29 (22.8) 22 (22.2)  
Physical activity at age 30, n (%)     0.176 
No 79 (19.0) 35 (21.1) 15 (11.8) 16 (16.2)  
Yes 331 (79.6) 128 (77.1) 110 (86.6) 82 (82.8)  
Body Mass Index, n (%)     0.272 
Non-obese (<30 kg/m2) 225 (54.1) 110 (66.3) 85 (66.9) 77 (77.8)  
Obese (≥30 kg/m2) 40 (9.6) 26 (15.7) 17 (13.4) 8 (8.1)  
Previous CVD disease, n (%)     0.901 
No 384 (92.3) 154 (92.8) 121 (95.3) 93 (93.9)  
Yes 17 (4.1) 6 (3.6) 4 (3.2) 5 (5.1)  
BP medication, n (%)*     0.085 
No 360 (86.5) 131 (78.9) 110 (86.6) 80 (80.8)  
Yes 56 (13.5) 35 (21.1) 17 (13.4) 19 (19.2)  
Non-ASA NSAIDs medication, n (%)     0.110 
No 404 (97.1) 154 (92.8) 121 (95.3) 93 (93.9)  
Yes 12 (2.9) 12 (7.2) 6 (4.7) 6 (6.1)  
Systolic BP, mmHg, mean (SD)* 
122.6 (18.4) 
130.7 
(19.9) 
127.4 (20.1) 132.8 (21.3) 0.000 
Total cholesterol, mg/dL, mean 
(SD)* 
6.5 (1.4) 7.0 (1.3) 6.7 (1.3) 7.1 (1.3) 0.000 
HDL-cholesterol, mg/dL, mean 
(SD)* 
1.7 (0.4) 1.7 (0.5) 1.8 (0.5) 1.7 (0.4) 0.168 
Glucose, mmol/L, mean (SD) 4.9 (0.7) 5.0 (0.7) 4.9 (0.5) 5.0 (0.8) 0.184 
OA=Osteoarthritis; IQR=Interquartile range; SD= Standard deviation; BP= blood pressure; HDL= High-density 
lipoprotein; NSAIDs=nonsteroidal anti-inflammatory drugs. *(Framingham Risk Score Factors) 
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Figure 2.  
All-cause mortality stratified by A) Knee status; and B) Hand status. Kaplan-Meier survival 
plots of all-cause mortality up to 23 years. 
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Table 4.  
Number of deaths (N) and Hazard Ratio (95%CI) of all-cause and disease specific mortality by KOA categories. 
Outcome 
KOA status 
No. of 
deaths (%) 
 Model 1 
P-value 
Model 2 
P-value 
Model 3 
P-value 
 HR 95%CI HR 95%CI HR 95%CI 
All-causes            
Neither ROA nor pain 84 (16.0)  1.00   1.00   1.00   
ROA only 14 (21.9)  0.95 0.54-1.69 0.865 1.01 0.57-1.80 0.968 1.05 0.58-1.88 0.876 
Pain only 46 (26.1)  1.49 1.04-2.14 0.029 1.55 1.07-2.22 0.019 1.44 0.99-2.08 0.055 
Painful ROA 22 (38.6)  1.97 1.23-3.17 0.005 2.06 1.27-3.33 0.003 1.97 1.20-3.22 0.007 
CVD disease            
Neither ROA nor pain 17 (3.2)  1.00   1.00   1.00   
ROA only 4 (6.3)  1.14 0.38-3.43 0.811 1.47 0.48-4.49 0.498 1.45 0.47-4.48 0.521 
Pain only 18 (10.2)  2.78 1.43-5.41 0.003 3.25 1.64-6.43 0.001 2.93 1.47-5.85 0.002 
Painful ROA 10 (17.5)  3.98 1.81-8.76 0.001 4.19 1.87-9.40 0.001 3.57 1.53-8.34 0.003 
Cancer disease            
Neither ROA nor pain 44 (8.4)  1.00   1.00   1.00   
ROA only 7 (10.9)  1.08 0.48-2.41 0.860 1.11 0.49-2.51 0.801 1.10 0.48-2.51 0.818 
Pain only 19(10.8)  1.23 0.72-2.12 0.444 1.23 0.72-2.12 0.451 1.12 0.64-1.94 0.693 
Painful ROA 6 (10.5)  1.17 0.49-2.78 0.719 1.33 0.56-3.16 0.523 1.18 0.49-2.88 0.712 
Model 1: adjusted for age 
Model 2: Model 1 + Smoking, total cholesterol, HDL-cholesterol, systolic BP and BP medication (Framingham Risk Score Factors) 
Model 3: Model 2 + occupation, BMI, HRT use, past physical activity, current/previous CVD disease, Non-ASA NSAIDs and glucose levels 
  
 30 
 
Table 4. Number of deaths (N) and Hazard Ratio (95%CI) of all-cause and disease specific mortality by hand OA categories. 
Outcome 
Hand OA status 
No. of 
deaths (%) 
 Model 1 
P-value 
Model 2 
P-value 
Model 3 
P-value 
 HR 95%CI HR 95%CI HR 95%CI 
All-causes            
Neither ROA nor pain 66 (15.9)  1.00   1.00   1.00   
ROA only 43 (25.9)  0.94 0.62-1.41 0.754 0.86 0.57-1.30 0.465 0.91 0.60-1.39 0.667 
Pain only 23 (18.1)  1.02 0.64-1.65 0.920 1.02 0.63-1.64 0.947 0.98 0.60-1.60 0.946 
Painful ROA 31 (31.3)  1.13 0.72-1.77 0.591 1.05 0.67-1.65 0.835 1.05 0.66-1.66 0.850 
CVD disease            
Neither ROA nor pain 18 (4.3)  1.00   1.00   1.00   
ROA only 10 (6.0)  0.60 0.27-1.34 0.212 0.48 0.21-1.10 0.081 0.57 0.25-1.33 0.196 
Pain only 10 (7.9)  1.54 0.71-3.33 0.276 1.66 0.75-3.66 0.210 1.53 0.67-3.50 0.313 
Painful ROA 8 (8.1)  0.80 0.34-1.91 0.620 0.76 0.32-1.82 0.541 0.75 0.30-1.87 0.539 
Cancer disease            
Neither ROA nor pain 33 (7.9)  1.00   1.00   1.00   
ROA only 22 (13.3)  1.28 0.71-2.29 0.407 1.24 0.69-2.24 0.477 1.27 0.70-2.30 0.432 
Pain only 9 (7.1)  0.85 0.41-1.78 0.665 0.83 0.39-1.75 0.626 0.78 0.34-1.66 0.522 
Painful ROA 12 (12.1)  1.17 0.58-2.35 0.662 1.13 0.55-2.29 0.743 1.16 0.57-2.39 0.679 
Model 1: adjusted for age 
Model 2: Model 1 + Smoking, total cholesterol, HDL-cholesterol, systolic BP and BP medication (Framingham Risk Score Factors) 
Model 3: Model 2 + occupation, BMI, HRT use, past physical activity, current/previous CVD disease, Non-ASA NSAIDs and glucose levels 
